Skip to content

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads

Return of nelfinavir's European license recommended

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

ICAAC: Sharp decline in HIV prevalence reported in pregnant women in rural northern Zimbabwe